rs16939660

Variant summary

Our verdict is Benign. The variant received -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2

The NM_003888.4(ALDH1A2):​c.453A>G​(p.Ala151Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00867 in 1,613,522 control chromosomes in the GnomAD database, including 105 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.014 ( 25 hom., cov: 32)
Exomes 𝑓: 0.0081 ( 80 hom. )

Consequence

ALDH1A2
NM_003888.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.111

Publications

9 publications found
Variant links:
Genes affected
ALDH1A2 (HGNC:15472): (aldehyde dehydrogenase 1 family member A2) This protein belongs to the aldehyde dehydrogenase family of proteins. The product of this gene is an enzyme that catalyzes the synthesis of retinoic acid (RA) from retinaldehyde. Retinoic acid, the active derivative of vitamin A (retinol), is a hormonal signaling molecule that functions in developing and adult tissues. The studies of a similar mouse gene suggest that this enzyme and the cytochrome CYP26A1, concurrently establish local embryonic retinoic acid levels which facilitate posterior organ development and prevent spina bifida. Four transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, May 2011]
ALDH1A2 Gene-Disease associations (from GenCC):
  • diaphragmatic hernia 4, with cardiovascular defects
    Inheritance: AR Classification: STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -19 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.46).
BP6
Variant 15-58010689-T-C is Benign according to our data. Variant chr15-58010689-T-C is described in ClinVar as Benign. ClinVar VariationId is 788449.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.111 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.014 (2139/152250) while in subpopulation AFR AF = 0.0327 (1360/41546). AF 95% confidence interval is 0.0313. There are 25 homozygotes in GnomAd4. There are 1016 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 25 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
ALDH1A2NM_003888.4 linkc.453A>G p.Ala151Ala synonymous_variant Exon 4 of 13 ENST00000249750.9 NP_003879.2 O94788-1
ALDH1A2NM_001206897.2 linkc.390A>G p.Ala130Ala synonymous_variant Exon 5 of 14 NP_001193826.1 O94788-3
ALDH1A2NM_170696.3 linkc.453A>G p.Ala151Ala synonymous_variant Exon 4 of 12 NP_733797.1 O94788-2
ALDH1A2NM_170697.3 linkc.165A>G p.Ala55Ala synonymous_variant Exon 2 of 11 NP_733798.1 O94788-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
ALDH1A2ENST00000249750.9 linkc.453A>G p.Ala151Ala synonymous_variant Exon 4 of 13 1 NM_003888.4 ENSP00000249750.4 O94788-1

Frequencies

GnomAD3 genomes
AF:
0.0141
AC:
2139
AN:
152132
Hom.:
25
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0328
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0117
Gnomad ASJ
AF:
0.00865
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00166
Gnomad FIN
AF:
0.00169
Gnomad MID
AF:
0.0127
Gnomad NFE
AF:
0.00775
Gnomad OTH
AF:
0.00719
GnomAD2 exomes
AF:
0.00835
AC:
2098
AN:
251216
AF XY:
0.00780
show subpopulations
Gnomad AFR exome
AF:
0.0309
Gnomad AMR exome
AF:
0.00944
Gnomad ASJ exome
AF:
0.00695
Gnomad EAS exome
AF:
0.000109
Gnomad FIN exome
AF:
0.00208
Gnomad NFE exome
AF:
0.00921
Gnomad OTH exome
AF:
0.00898
GnomAD4 exome
AF:
0.00811
AC:
11845
AN:
1461272
Hom.:
80
Cov.:
31
AF XY:
0.00785
AC XY:
5709
AN XY:
726984
show subpopulations
African (AFR)
AF:
0.0334
AC:
1116
AN:
33452
American (AMR)
AF:
0.00966
AC:
432
AN:
44704
Ashkenazi Jewish (ASJ)
AF:
0.00712
AC:
186
AN:
26114
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39694
South Asian (SAS)
AF:
0.00155
AC:
134
AN:
86246
European-Finnish (FIN)
AF:
0.00264
AC:
141
AN:
53406
Middle Eastern (MID)
AF:
0.0128
AC:
74
AN:
5762
European-Non Finnish (NFE)
AF:
0.00828
AC:
9200
AN:
1111532
Other (OTH)
AF:
0.00926
AC:
559
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.477
Heterozygous variant carriers
0
619
1238
1856
2475
3094
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
350
700
1050
1400
1750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0140
AC:
2139
AN:
152250
Hom.:
25
Cov.:
32
AF XY:
0.0137
AC XY:
1016
AN XY:
74430
show subpopulations
African (AFR)
AF:
0.0327
AC:
1360
AN:
41546
American (AMR)
AF:
0.0117
AC:
179
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.00865
AC:
30
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00166
AC:
8
AN:
4826
European-Finnish (FIN)
AF:
0.00169
AC:
18
AN:
10620
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00773
AC:
526
AN:
68012
Other (OTH)
AF:
0.00712
AC:
15
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.497
Heterozygous variant carriers
0
105
210
314
419
524
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0111
Hom.:
47
Bravo
AF:
0.0160
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.00823
EpiControl
AF:
0.00901

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Dec 31, 2019
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

ALDH1A2-related disorder Benign:1
Mar 06, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.46
CADD
Benign
10
DANN
Benign
0.63
PhyloP100
-0.11
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=96/4
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16939660; hg19: chr15-58302887; API